Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

2 Part, Phase II Study of Intravenous, Single Ascending Dose Administrations of IOP Injection in Patients With Iron Deficient Anemia

NCT03485053 is registered in ClinicalTrials.gov with MegaPro Biomedical Co. Ltd. as lead sponsor.

NCT NCT03485053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03485053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
2 Part, Phase II Study of Intravenous, Single Ascending Dose Administrations of IOP Injection in Patients With Iron Deficient Anemia
Lead sponsor
MegaPro Biomedical Co. Ltd.
Phase
Phase 2
Overall status
Terminated
Start date
November 29, 2018
Completion date
August 31, 2021
Enrollment
49 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

iron deficiency anemia